Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials.

Clin Exp Med · 2023 · PMC9435420 · PMID 36048371

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Efficacy of therapeutic-dose low-molecular-weight heparin For the efficacy outcome, the fixed effects model showed a trend for lower all-cause death during hospitalization in patients with therapeutic-dose anticoagulation compared with thromboprophylaxis (RR 0.85; 95% confidence interval [CI] 0.67–1.07; P = 0.16; I 2 = 48%) (Fig. 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.